This webinar, hosted by Cromos Pharma with MKR Clinical Research Consultants (29 May 2020), explores strategic approaches to getting clinical trials back on track amid the ongoing COVID-19 pandemic. It also featured insights into optimal country choices to maximize enrolment as regions begin to reopen and lift pandemic restrictions.
“Using a scenario-based modelling approach the Cromos Pharma team has developed a comprehensive roadmap for sponsors to help them optimize recovery and get their trials back on track in the coming months,” said Dr Vlad Bogin, CEO, Cromos Pharma.
The roadmap to recovery developed by Cromos Pharma is based on an evidence-based approach and extensive risk-assessment. It aims to ensure that sponsors can get trials back up and running in the most effective manner possible.
If you would like further information on Cromos Pharma’s roadmap to recovery, please email firstname.lastname@example.org